Implantable wireless powered light emitting diode (LED) for near-infrared photoimmunotherapy: device development and experimental assessment  in vitro  and  in vivo

Kohei Nakajima; Toshihiro Kimura; Hideo Takakura; Yasuo Yoshikawa; Atsushi Kameda; Takayuki Shindo; Kazuhide Sato; Hisataka Kobayashi; Mikako Ogawa

doi:10.18632/oncotarget.25068

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Implantable wireless powered light emitting diode (LED) for near-infrared photoimmunotherapy: device development and experimental assessment in vitro and in vivo

Kohei Nakajima, Toshihiro Kimura, Hideo Takakura, Yasuo Yoshikawa, Atsushi Kameda, Takayuki Shindo, Kazuhide Sato, Hisataka Kobayashi and Mikako Ogawa _

PDF | HTML | How to cite

Oncotarget. 2018; 9:20048-20057. https://doi.org/10.18632/oncotarget.25068

Metrics: PDF 2428 views | HTML 3146 views | ?

Abstract

Kohei Nakajima1, Toshihiro Kimura1,2,4, Hideo Takakura1, Yasuo Yoshikawa3, Atsushi Kameda4, Takayuki Shindo4, Kazuhide Sato5, Hisataka Kobayashi5 and Mikako Ogawa1,6

1Laboratory of Bioanalysis and Molecular Imaging, Graduate School of Pharmaceutical Sciences, Hokkaido University, Sapporo, Hokkaido, Japan

2Savior, Inc., Yokohama, Kanagawa, Japan

3Piolax Medical Devices, Inc., Yokohama, Kanagawa, Japan

4B and Plus K.K., Ogawamachi, Saitama, Japan

5Molecular Imaging Program, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, USA

6Presto, Japan Science and Technology Agency, Kawaguchi, Saitama, Japan

Correspondence to:

Mikako Ogawa, email: [email protected]

Hisataka Kobayashi, email: [email protected]

Keywords: light emitting diode (LED); wireless power transfer; phototherapy; near-infrared photoimmunotherapy (NIR-PIT)

Received: February 16, 2018 Accepted: March 21, 2018 Published: April 13, 2018

ABSTRACT

Purpose: The aim of this study was to develop and assess a novel implantable, wireless-powered, light-emitting diode (LED) for near-infrared photoimmunotherapy (NIR-PIT). NIR-PIT is a recently developed cancer therapy that uses NIR light and antibody-photosensitizer conjugates and is able to induce cancer-specific cell death. Due to limited light penetration depth it is currently unable to treat tumors in deep tissues. Use of implanted LED might potentially overcome this limitation.

Results: The wireless LED system was able to emit NIR light up to a distance of 20 cm from the transmitter coil by using low magnetic fields as compliant with limits for use in humans. Results indicated that the LED system was able to kill tumor cells in vitro and to suppress tumor growth in implanted tumor-bearing mice.

Conclusions: Results indicated that the proposed implantable wireless LED system was able to suppress tumor growth in vivo. These results are encouraging as wireless LED systems such as the one here developed might be a possible solution to treat tumors in deep regions in humans. Further research in this area would be important.

Materials and Methods: An implantable LED system was developed. It consisted of a LED capsule including two LED sources and a receiver coil coupled with an external coil and power source. Wireless power transmission was guaranteed by using electromagnetic induction. The system was tested in vitro by using EGFR-expressing cells and HER2-expressing cells. The system was also tested in vivo in tumor-bearing mice.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 25068

Publication Alerts

Research Papers:

Implantable wireless powered light emitting diode (LED) for near-infrared photoimmunotherapy: device development and experimental assessment in vitro and in vivo

Abstract